Patents by Inventor Ei-ichiro SUNAMURA

Ei-ichiro SUNAMURA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220170917
    Abstract: A problem to be solved is to perform an immunoassay method for BG in a biological sample having a sensitivity equivalent to and a reactivity similar to a Limulus amebocyte lysate reagent. The problem can be solved by an immunoassay method for ?-D-glucan in a biological sample, comprising assaying ?-D-glucan in the biological sample by using a monoclonal antibody binding to (1?3)-?-D-glucan having a degree of polymerization of 4.
    Type: Application
    Filed: March 6, 2020
    Publication date: June 2, 2022
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Ei-ichiro SUNAMURA, Osamu MIYAZAKI, Takuya YOTANI, Shinichiro KITAHARA, Manami IWASAKI
  • Publication number: 20210270821
    Abstract: A problem to be solved is to perform an immunoassay method for BG in a biological sample simply operated and having a sensitivity equivalent to that of a Limulus reagent. The problem can be solved by combining a pretreatment of a biological samples with an alkaline solution and a use of anti-BG monoclonal antibody specifically reacting with BG.
    Type: Application
    Filed: July 26, 2019
    Publication date: September 2, 2021
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Ei-ichiro SUNAMURA, Takuya YOTANI
  • Publication number: 20200393472
    Abstract: Provided is a method for separating and detecting various hemoglobins including abnormal hemoglobins and thalassemia markers. A method for analyzing hemoglobins, comprising separating hemoglobins in a sample by cation exchange chromatography, wherein an eluent having a pH of 8.1 or more and an osmotic pressure of 40 mOsm/kg or less is used for separation of the hemoglobins.
    Type: Application
    Filed: April 18, 2019
    Publication date: December 17, 2020
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Hiroaki TAIRA, Ei-ichiro SUNAMURA, Kohei MATSUDA, Takuya YOTANI
  • Publication number: 20200216909
    Abstract: It is intended to provide highly sensitive and specific, rapid, and convenient method for evaluating a risk of hepatocellular carcinoma. The method for evaluating a risk of hepatocellular carcinoma comprises: (1) amplifying bisulfite-treated DNA derived from a liver tissue of a subject, wherein the DNA comprises a CpG site of an exon region of MGRN1 gene; (2) subjecting the obtained amplification product to ion exchange chromatography; and (3) determining whether or not the DNA is DNA obtained from a subject having a high risk of development of hepatocellular carcinoma on the basis of a peak shape of a detection signal of the chromatography.
    Type: Application
    Filed: August 23, 2018
    Publication date: July 9, 2020
    Applicants: NATIONAL CANCER CENTER, SEKISUI MEDICAL CO., LTD.
    Inventors: Yae KANAI, Eri ARAI, Takuya YOTANI, Ei-ichiro SUNAMURA